Tetramer assay

Tetramer assay is a scientific method used in the field of immunology to quantify the number of T cells in a sample that are specific for a particular antigen. This technique is often used in research and clinical settings to monitor immune responses.

Overview

The tetramer assay is based on the principle that T cells recognize and bind to specific antigens presented by Major Histocompatibility Complex (MHC) molecules. In this assay, MHC molecules are engineered to present a specific antigen and are then combined to form a tetramer, a complex of four MHC-antigen pairs. When a sample containing T cells is added, those T cells that are specific for the antigen will bind to the tetramer. The bound T cells can then be counted, providing a measure of the immune response to that antigen.

Procedure

The procedure for a tetramer assay involves several steps:

1. Preparation of the tetramer: MHC molecules are engineered to present a specific antigen and are then combined to form a tetramer.
2. Incubation with the sample: The tetramer is added to a sample containing T cells. Those T cells that are specific for the antigen will bind to the tetramer.
3. Detection of bound T cells: The bound T cells are then detected and counted, usually using flow cytometry.

Applications

Tetramer assays have a wide range of applications in both research and clinical settings. They are often used to monitor immune responses in individuals with infectious diseases, autoimmune disorders, and cancer. They can also be used to evaluate the efficacy of vaccines and immunotherapies.

Limitations

While tetramer assays are a powerful tool for quantifying antigen-specific T cells, they do have some limitations. For example, they can only detect T cells that are specific for the antigen presented by the tetramer. Therefore, they may not provide a complete picture of the immune response if other antigens are also involved.

See also

• Immunology
• T cell
• Antigen
• Major Histocompatibility Complex (MHC)
• Flow cytometry

• An MHC tetramer binding to T-cell receptors (left), and an MHC molecule on the surface of an antigen presenting cell binding to T-cell receptors (right).
  An MHC tetramer binding to T-cell receptors (left), and an MHC molecule on the surface of an antigen presenting cell binding to T-cell receptors (right).